The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Neurodegeneration in multiple sclerosis and neuromyelitis optica
Open accessAbstract
Multiple sclerosis (MS) and neuromyelitis optica (NMO) are autoimmune demyelinating diseases of the central nervous system (CNS), having distinct immunological and pathological features. They have two pathogenic components, 'inflammation' and 'neurodegeneration', with different degrees of severity and pathogenetic mechanisms. The target antigen of autoimmunity in NMO is the water channel aquaporin-4 (AQP4), and antibodies directed against this antigen result in astrocyte damage. MS is a disease primarily affecting myelin and oligodendrocytes, but thus far, no MS-specific autoantigen has been identified. The distinct inflammatory processes in these diseases may trigger cascades of events leading to disease-specific neurodegeneration. Damage of the CNS tissue appears to be amplified by mechanisms that are in part shared by the two conditions and involve oxidative burst activation in microglia/macrophages, mitochondrial damage and axonal energy failure, Wallerian degeneration and meningeal inflammation. However, they appear to differ regarding the nature of the inflammatory response, the type and extent of cortical injury, and the type of astrocyte reaction and damage. Here, we provide a detailed comparison of the pathology between MS and NMO, which may help to define shared and disease-specific mechanisms of neurodegeneration in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationPeterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J. (2014) · Neurology · doi:10.1212/wnl.0000000000000768 · Cited by 1,223
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Coles, A. J., Twyman, C. L., Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61768-1 · Cited by 1,198
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Self-citationInflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103
Self-citationMitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases
Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,102
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Self-citationHawker, K., O'Connor, P., Freedman, M. S., Calabresi, P. A., Antel, J., Simon, J., Hauser, S., Waubant, E., Vollmer, T., Panitch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21867 · Cited by 934
Lymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908
Kuhlmann, T. (2002) · Brain · doi:10.1093/brain/awf235 · Cited by 775
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Self-citationA reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713 · cited 1×
“61 These axonal structural changes that are consistent with focal axonal degeneration/ swelling are present in acute MS lesions, 61 in demyelinated axons of chronic inactive MS lesions 62 or in remyelinated axons in the MS brain.”
BackgroundScalfari, A., Neuhaus, A., Degenhardt, A., Rice, G. P., Muraro, P. A., Daumer, M., & Ebers, G. C. (2010) · Brain · doi:10.1093/brain/awq118 · Cited by 711
Brain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
MRI characteristics of neuromyelitis optica spectrum disorder: An international update
Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001367 · Cited by 664
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · cited 2×
“67 Third, ‘ genuine hypoxia ’ also plays an important role in neurodegeneration in MS. Focal demyelinated lesions in the WM occurred not only at sites with high venous density but also in watershed areas of low arterial blood supply.”
BackgroundLoss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Wallerian degeneration: an emerging axon death pathway linking injury and disease
Conforti, L., Gilley, J., & Coleman, M. P. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3680 · Cited by 611
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Calabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi, V., Barachino, L., Rinaldi, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.174 · Cited by 555
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Self-citationGrey matter pathology in multiple sclerosis
Geurts, J. J., & Barkhof, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70191-1 · Cited by 507
Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507
Self-citationWill the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., Mascanfroni, I. D., Yeste, A., Kivisäkk, P., Kallas, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3681 · Cited by 472
Mitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
Self-citationLublin, F., Miller, D. H., Freedman, M. S., Cree, B. A. C., Wolinsky, J. S., Weiner, H., Lubetzki, C., Hartung, H.-P., Montalban, X., Uitdehaag, B. M. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01314-8 · Cited by 448
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Haider, L., Zrzavy, T., Hametner, S., Höftberger, R., Bagnato, F., Grabner, G., Trattnig, S., Pfeifenbring, S., Brück, W., & Lassmann, H. (2016) · Brain · doi:10.1093/brain/awv398 · Cited by 400
Self-citationMitochondrial DNA deletions and neurodegeneration in multiple sclerosis
Campbell, G. R., Ziabreva, I., Reeve, A. K., Krishnan, K. J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2011) · Annals of Neurology · doi:10.1002/ana.22109 · Cited by 386
Self-citationImaging outcomes for neuroprotection and repair in multiple sclerosis trials
Barkhof, F., Calabresi, P. A., Miller, D. H., & Reingold, S. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.41 · Cited by 378
Haider, L., Simeonidou, C., Steinberger, G., Hametner, S., Grigoriadis, N., Deretzi, G., Kovacs, G. G., Kutzelnigg, A., Lassmann, H., & Frischer, J. M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307712 · Cited by 357
Self-citationHinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081241 · Cited by 355
Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis
Kutzelnigg, A., Faber‐Rod, J. C., Bauer, J., Lucchinetti, C. F., Sorensen, P. S., Laursen, H., Stadelmann, C., Brück, W., Rauschka, H., Schmidbauer, M., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00041.x · Cited by 336
Self-citationMolecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 328
A secondary progressive clinical course is uncommon in neuromyelitis optica
Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., Lennon, V. A., & Weinshenker, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000254502.87233.9a · Cited by 326
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
Dutta, R., Chang, A., Doud, M. K., Kidd, G. J., Ribaudo, M. V., Young, E. A., Fox, R. J., Staugaitis, S. M., & Trapp, B. D. (2011) · Annals of Neurology · doi:10.1002/ana.22337 · Cited by 315
Disease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311
Self-citationSormani, M. P., Arnold, D. L., & De Stefano, N. (2014) · Annals of Neurology · doi:10.1002/ana.24018 · Cited by 297
Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications
Popescu, B. F. G., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gómez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., Weinshenker, B. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318214332c · Cited by 296
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 294
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007) · Brain · doi:10.1093/brain/awm236 · Cited by 292
Self-citationMitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Self-citationThe astrocyte in multiple sclerosis revisited
Brosnan, C. F., & Raine, C. S. (2013) · Glia · doi:10.1002/glia.22443 · Cited by 259
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514567216 · Cited by 252
Regional grey matter atrophy in clinically isolated syndromes at presentation
Henry, R. G., Shieh, M., Okuda, D. T., Evangelista, A., Gorno-Tempini, M. L., & Pelletier, D. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.134825 · Cited by 238
Misu, T., Höftberger, R., Fujihara, K., Wimmer, I., Takai, Y., Nishiyama, S., Nakashima, I., Konno, H., Bradl, M., Garzuly, F., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1116-7 · Cited by 232
Self-citationPostmortem verification of MS cortical lesion detection with 3D DIR
Seewann, A., Kooi, E.-J., Roosendaal, S. D., Pouwels, P. J. W., Wattjes, M. P., van der Valk, P., Barkhof, F., Polman, C. H., & Geurts, J. J. G. (2012) · Neurology · doi:10.1212/wnl.0b013e31824528a0 · Cited by 229
Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis
Schoonheim, M. M., Hulst, H. E., Brandt, R. B., Strik, M., Wink, A. M., Uitdehaag, B. M. J., Barkhof, F., & Geurts, J. J. G. (2015) · Neurology · doi:10.1212/wnl.0000000000001285 · Cited by 226
Early CNS neurodegeneration in radiologically isolated syndrome
Azevedo, C. J., Overton, E., Khadka, S., Buckley, J., Liu, S., Sampat, M., Kantarci, O., Lebrun Frenay, C., Siva, A., Okuda, D. T., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000102 · Cited by 216
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Sinnecker, T., Dörr, J., Pfueller, C. F., Harms, L., Ruprecht, K., Jarius, S., Brück, W., Niendorf, T., Wuerfel, J., & Paul, F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182648bc8 · Cited by 214
Schattling, B., Steinbach, K., Thies, E., Kruse, M., Menigoz, A., Ufer, F., Flockerzi, V., Brück, W., Pongs, O., Vennekens, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.3015 · Cited by 206
Axonal Pathology in Multiple Sclerosis. A Historical Note
Kornek, B., & Lassmann, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00547.x · Cited by 197
Self-citationHohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00334-8 · Cited by 197
Harrison, D. M., Roy, S., Oh, J., Izbudak, I., Pham, D., Courtney, S., Caffo, B., Jones, C. K., van Zijl, P., & Calabresi, P. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1241 · Cited by 196
Neurodegeneration and the neurovascular unit
Zlokovic, B. V. (2010) · Nature Medicine · doi:10.1038/nm1210-1370 · Cited by 189
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
Shimizu, J., Hatanaka, Y., Hasegawa, M., Iwata, A., Sugimoto, I., Date, H., Goto, J., Shimizu, T., Takatsu, M., Sakurai, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8832e · Cited by 188
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
Wylezinska, M., Cifelli, A., Jezzard, P., Palace, J., Alecci, M., & Matthews, P. M. (2003) · Neurology · doi:10.1212/01.wnl.0000069464.22267.95 · Cited by 186
Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00313-0 · Cited by 180
Cognitive impairment and cortical degeneration in neuromyelitis optica
Saji, E., Arakawa, M., Yanagawa, K., Toyoshima, Y., Yokoseki, A., Okamoto, K., Otsuki, M., Akazawa, K., Kakita, A., Takahashi, H., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23721 · Cited by 174
Self-citationWallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis
Dziedzic, T., Metz, I., Dallenga, T., König, F. B., Müller, S., Stadelmann, C., & Brück, W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00401.x · Cited by 173
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Brück, W., Pförtner, R., Pham, T., Zhang, J., Hayardeny, L., Piryatinsky, V., Hanisch, U.-K., Regen, T., van Rossum, D., Brakelmann, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1009-1 · Cited by 168
Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis
Rocca, M. A., Mesaros, S., Pagani, E., Sormani, M. P., Comi, G., & Filippi, M. (2010) · Radiology · doi:10.1148/radiol.10100326 · Cited by 165
Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis
Zambonin, J. L., Zhao, C., Ohno, N., Campbell, G. R., Engeham, S., Ziabreva, I., Schwarz, N., Lee, S. E., Frischer, J. M., Turnbull, D. M., et al. (2011) · Brain · doi:10.1093/brain/awr110 · Cited by 162
Self-citationKaneko, S., Wang, J., Kaneko, M., Yiu, G., Hurrell, J. M., Chitnis, T., Khoury, S. J., & He, Z. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2116-06.2006 · Cited by 159
Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
Androdias, G., Reynolds, R., Chanal, M., Ritleng, C., Confavreux, C., & Nataf, S. (2010) · Annals of Neurology · doi:10.1002/ana.22054 · Cited by 151
Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody
Yokoseki, A., Saji, E., Arakawa, M., Kosaka, T., Hokari, M., Toyoshima, Y., Okamoto, K., Takeda, S., Sanpei, K., Kikuchi, H., et al. (2013) · Brain · doi:10.1093/brain/awt314 · Cited by 142
Self-citationEosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica
Zhang, H., & Verkman, A. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67554 · Cited by 135
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS
Nielsen, A. S., Kinkel, R. P., Madigan, N. K., Tinelli, E., Benner, T., & Mainero, C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a08ce8 · Cited by 135
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS
Rudick, R. A., Lee, J. C., Nakamura, K., & Fisher, E. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.11.018 · Cited by 133
White-Matter Astrocytes, Axonal Energy Metabolism, and Axonal Degeneration in Multiple Sclerosis
Cambron, M., D’haeseleer, M., Laureys, G., Clinckers, R., Debruyne, J., & Keyser, J. D. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.193 · Cited by 132
No MRI evidence of cortical lesions in neuromyelitis optica
Calabrese, M., Oh, M. S., Favaretto, A., Rinaldi, F., Poretto, V., Alessio, S., Lee, B., Yu, K., Ma, H., Perini, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9a96 · Cited by 125
Absence of cortical demyelination in neuromyelitis optica
Popescu, B. F. G., Parisi, J. E., Cabrera-Gómez, J. A., Newell, K. L., Mandler, R. N., Pittock, S. J., Lennon, V. A., Weinshenker, B. G., & Lucchinetti, C. F. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d80c · Cited by 120
Schirmer, L., Antel, J. P., Brück, W., & Stadelmann, C. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00466.x · Cited by 119
Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors
Keyser, J. D., Wilczak, N., Leta, R., & Streetland, C. (1999) · Neurology · doi:10.1212/wnl.53.8.1628 · Cited by 114
Cause and prevention of demyelination in a model multiple sclerosis lesion
Desai, R. A., Davies, A. L., Tachrount, M., Kasti, M., Laulund, F., Golay, X., & Smith, K. J. (2016) · Annals of Neurology · doi:10.1002/ana.24607 · Cited by 102
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns
Hauser, S. L. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514561911 · Cited by 101
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J. J. G., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 96
T cell-activation in neuromyelitis optica lesions plays a role in their formation
Hastermann, M., Kawakami, N., Kitic, M., Bauer, J., Martins, R., Fischer, M.-T., Machado-Santos, J., Mader, S., Ellwart, J. W., Misu, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-85 · Cited by 94
Self-citationBlauth, K., Soltys, J. N., Matschulat, A. M., Reiter, C. R., Ritchie, A. M., Baird, N. L., Bennett, J. L., & Owens, G. P. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1500-6 · Cited by 94
Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis
Yanagawa, K., Kawachi, I., Toyoshima, Y., Yokoseki, A., Arakawa, M., Hasegawa, A., Ito, T., Kojima, N., Koike, R., Tanaka, K., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1deb9 · Cited by 93
Self-citationSic, H., Kraus, H., Madl, J., Flittner, K.-A., von Münchow, A. L., Pieper, K., Rizzi, M., Kienzler, A., Ayata, C. K., Rauer, S., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.037 · Cited by 87
Ratelade, J., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297275 · Cited by 77
Clinicopathological features in anterior visual pathway in neuromyelitis optica
Hokari, M., Yokoseki, A., Arakawa, M., Saji, E., Yanagawa, K., Yanagimura, F., Toyoshima, Y., Okamoto, K., Ueki, S., Hatase, T., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24608 · Cited by 77
Self-citationUltrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica
Kister, I., Herbert, J., Zhou, Y., & Ge, Y. (2013) · Multiple Sclerosis International · doi:10.1155/2013/398259 · Cited by 75
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
Kremer, S., Renard, F., Achard, S., Lana–Peixoto, M. A., Palace, J. A., Asgari, N., Klawiter, E. C., Tenembaum, S. N., Banwell, B., Greenberg, B. M., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0248 · Cited by 66
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD
Finke, C., Heine, J., Pache, F. C., Lacheta, A., Borisow, N., Kuchling, J., Bellmann–Strobl, J., Ruprecht, K., Brandt, A. U., & Paul, F. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000229 · Cited by 66
Geis, C., Ritter, C., Ruschil, C., Weishaupt, A., Grünewald, B., Stoll, G., Holmøy, T., Misu, T., Fujihara, K., Hemmer, B., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.015 · Cited by 61
Differential effects of fingolimod on B-cell populations in multiple sclerosis
Nakamura, M., Matsuoka, T., Chihara, N., Miyake, S., Sato, W., Araki, M., Okamoto, T., Lin, Y., Ogawa, M., Murata, M., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514523496 · Cited by 59
Kira, J., Itoyama, Y., Kikuchi, S., Hao, Q., Kurosawa, T., Nagato, K., Tsumiyama, I., von Rosenstiel, P., Zhang-Auberson, L., & Saida, T. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-21 · Cited by 57
Substantial early, but nonprogressive neuronal loss in multiple sclerosis (ms) spinal cord
Schirmer, L., Albert, M., Buss, A., Schulz‐Schaeffer, W. J., Antel, J. P., Brück, W., & Stadelmann, C. (2009) · Annals of Neurology · doi:10.1002/ana.21799 · Cited by 56
Montalbán, X., Hemmer, B., Rammohan, K. W., Giovannoni, G., Seze, J. D., Bar‐Or, A., Arnold, D. L., Sauter, A., Kakarieka, A., Masterman, D. L., et al. (2015) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) · Cited by 50
Herwerth, M., Kalluri, S. R., Srivastava, R., Kleele, T., Kenet, S., Illés, Z., Merkler, D., Bennett, J. L., Misgeld, T., & Hemmer, B. (2016) · Annals of Neurology · doi:10.1002/ana.24630 · Cited by 48
Demyelination and neurodegeneration in multiple sclerosis: The role of hypoxia
Lassmann, H. (2016) · Annals of Neurology · doi:10.1002/ana.24632 · Cited by 23
Self-citationSignificance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica
Kawachi, I., & Nishizawa, M. (2015) · Neuropathology · doi:10.1111/neup.12216 · Cited by 13
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cited by
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Hor, J. Y., Asgari, N., Nakashima, I., Broadley, S. A., Leite, M. I., Kissani, N., Jacob, A., Marignier, R., Weinshenker, B. G., Paul, F., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00501 · Cited by 413
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
Carnero Contentti, E., & Correale, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02249-1 · Cited by 338
Eid, R., Arab, N. T. T., & Greenwood, M. T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 288
on behalf of the MAGNIMS study group, Sastre-Garriga, J., Pareto, D., Battaglini, M., Rocca, M. A., Ciccarelli, O., Enzinger, C., Wuerfel, J., Sormani, M. P., Barkhof, F., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0314-x · Cited by 273
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Watanabe, M., Nakamura, Y., Michalak, Z., Isobe, N., Barro, C., Leppert, D., Matsushita, T., Hayashi, F., Yamasaki, R., Kuhle, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008160 · Cited by 220
Metadata
- Authors
- Kawachi, I., & Lassmann, H.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2016-09-26
- Volume
- 88
- Issue
- 2
- Pages
- 137-145
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2524845362
- Cited by
- 283
- References
- 109
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.